Yi Huan
Peking Union Medical College | China
Biography
Yi Huan has her expertise in discovery and development of novel anti-diabetic drugs. She established a variety of pharmacological methods and technologies to screen compounds, evaluate the activities of anti-diabetic agents. Now she is focusing on the discovery of novel anti-diabetic candidates, such as SGLT2 inhibitors, GPR119/40/120 agonists, FXR agonists and selective PPAR activators. Some of the anti-diabetic candidates she found have been developed into pre-clinical research up to date. She is nterested in pharmacological mechanism research and devotes into elucidation of the anti-diabetic effect of new drugs.
Abstract
Abstract : Discovery of GPR119/DPP4 dual-target compounds as anti-diabetic candidates